ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 667472 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 667472; 2) Community: the network communities that were significantly associated with the response to NSC 667472; 3) Molecule: the relationships between components within communities and NSC 667472; 4) MDR: the compounds that were significantly associated with the NSC 667472.

NSC Compound Enrichment Correlation
NSC 703105 Null 0.00415749398947839 0.25461087
NSC 709483 Null 0.00415749398947839 0.22344798
NSC 728035 1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di 0.00415749398947839 0.40312371
NSC 740 Methotrexate 0.00415749398947839 0.23768116
NSC 744063 Null 0.00415749398947839 0.48003707
NSC 79093 5-Hydroxy-6,7,8,4'-tetramethoxyflavone 0.00415749398947839 0.13184448
NSC 87222 ACTINOMYCIN C3 0.00415749398947839 0.28863282
NSC 114346 Null 0.0041872854493286 0.31600304
NSC 129794 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) 0.0041872854493286 0.3099004
NSC 135880 Null 0.0041872854493286 0.32975327
Total:138  Current:17    [First] [Prev] [Next] [Last]